You are here

  • Home
  • Archive
  • Volume 97, Issue 2
  • Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies

Article info

Article menu
Download PDFPDF
Genetics of heart disease
Original article
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies

Authors

  1. Correspondence to Professor J Wouter Jukema, Leiden University Medical Center, Department of Cardiology, C5-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands; j.w.jukema{at}lumc.nl
View Full Text

Citation

Pons D, Trompet S, de Craen AJM, et al
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies
Heart 2011;97:143-150.

Publication history

  • Accepted October 5, 2010
  • First published November 8, 2010.
Online issue publication 
May 30, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.